Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese

NCT06732245 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity and Overweight

Interventions

DRUG: NA-931
DRUG: Tirzepatide
DRUG: Tirzepatide
DRUG: NA-931
DRUG: NA-931
DRUG: NA-931
DRUG: NA-931 150 mg + no Tirzepatide
DRUG: NA-931
DRUG: NA-931

Sponsor

Biomed Industries, Inc.

Collaborators

[object Object]